259 related articles for article (PubMed ID: 3621844)
1. Giant cell arteritis precipitated by a diagnostic trial of prednisolone in suspected polymyalgia rheumatica.
Reilly PA; Maddison PJ
Clin Rheumatol; 1987 Jun; 6(2):270-2. PubMed ID: 3621844
[TBL] [Abstract][Full Text] [Related]
2. Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach.
Borresen SW; Thorgrimsen TB; Jensen B; Hilsted L; Bartels EM; Feldt-Rasmussen U; Locht H
Rheumatology (Oxford); 2020 Oct; 59(10):2764-2773. PubMed ID: 32031663
[TBL] [Abstract][Full Text] [Related]
3. Treatment of polymyalgia rheumatica/giant cell arteritis.
Kyle V
Baillieres Clin Rheumatol; 1991 Dec; 5(3):485-91. PubMed ID: 1807823
[TBL] [Abstract][Full Text] [Related]
4. Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months.
Kyle V; Hazleman BL
Ann Rheum Dis; 1989 Aug; 48(8):658-61. PubMed ID: 2782975
[TBL] [Abstract][Full Text] [Related]
5. Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects.
Kyle V; Hazleman BL
Ann Rheum Dis; 1989 Aug; 48(8):662-6. PubMed ID: 2782976
[TBL] [Abstract][Full Text] [Related]
6. Polymyalgia rheumatica and corticosteroids: how much for how long?
Behn AR; Perera T; Myles AB
Ann Rheum Dis; 1983 Aug; 42(4):374-8. PubMed ID: 6882032
[TBL] [Abstract][Full Text] [Related]
7. [A case of giant cell arteritis after prednisolone dose reduction during treatment of polymyalgia rheumatica].
Yamashita M; Aoki A; Kobayashi H; Wakiya M; Nakatsugawa M
Nihon Ronen Igakkai Zasshi; 2023; 60(4):440-447. PubMed ID: 38171762
[TBL] [Abstract][Full Text] [Related]
8. Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol.
Emamifar A; Hess S; Gerke O; Hermann AP; Laustrup H; Hansen PS; Thye-Rønn P; Marcussen N; Svendstrup F; Gildberg-Mortensen R; Bang JC; Farahani ZA; Chrysidis S; Toftegaard P; Andreasen RA; le Greves S; Andersen HR; Olsen RN; Hansen IMJ
Medicine (Baltimore); 2017 Jun; 96(26):e7297. PubMed ID: 28658131
[TBL] [Abstract][Full Text] [Related]
9. Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study.
De Silva M; Hazleman BL
Ann Rheum Dis; 1986 Feb; 45(2):136-8. PubMed ID: 3511861
[TBL] [Abstract][Full Text] [Related]
10. Polymyalgia rheumatica and giant cell arteritis--An ophthalmic emergency.
Durkin SR; Athanasiov PA; Crompton JL
Aust Fam Physician; 2006 Nov; 35(11):889-91. PubMed ID: 17099810
[TBL] [Abstract][Full Text] [Related]
11. Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
Pioro MH
Prim Care; 2018 Jun; 45(2):305-323. PubMed ID: 29759126
[TBL] [Abstract][Full Text] [Related]
12. Polymyalgia rheumatica and its links with giant cell arteritis.
Charlton R
Clin Med (Lond); 2008 Oct; 8(5):498-501. PubMed ID: 18975481
[TBL] [Abstract][Full Text] [Related]
13. Death from unsuspected diverticular disease in patients taking corticosteroids for polymyalgia rheumatica or giant cell arteritis.
Bowman S; Paice E; Binder A
Br J Rheumatol; 1991 Apr; 30(2):159-60. PubMed ID: 2012956
[No Abstract] [Full Text] [Related]
14. Polymyalgia rheumatica and giant cell arteritis.
Myles AB
BMJ; 1995 Nov; 311(7014):1232. PubMed ID: 7488934
[No Abstract] [Full Text] [Related]
15. [Polymyalgia rheumatica and giant-cell temporal arteritis].
Tereshchenko IV
Klin Med (Mosk); 2006; 84(8):25-30. PubMed ID: 17087187
[TBL] [Abstract][Full Text] [Related]
16. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
[TBL] [Abstract][Full Text] [Related]
17. Prednisolone maintenance dose in relation to starting dose in the treatment of polymyalgia rheumatica and temporal arteritis. A prospective two-year study in 273 patients.
Myklebust G; Gran JT
Scand J Rheumatol; 2001; 30(5):260-7. PubMed ID: 11727839
[TBL] [Abstract][Full Text] [Related]
18. The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment.
Kyle V; Hazleman BL
Ann Rheum Dis; 1993 Dec; 52(12):847-50. PubMed ID: 8311533
[TBL] [Abstract][Full Text] [Related]
19. Circulating T cell subtypes in polymyalgia rheumatica and giant cell arteritis: variation in the percentage of CD8+ cells with prednisolone treatment.
Pountain GD; Keogan MT; Brown DL; Hazleman BL
Ann Rheum Dis; 1993 Oct; 52(10):730-3. PubMed ID: 8257209
[TBL] [Abstract][Full Text] [Related]
20. [Polymyalgia rheumatica and Giant Cell Arteritis - Update on Diagnosis and Therapy].
Becker M
Praxis (Bern 1994); 2020; 109(5):347-354. PubMed ID: 32233763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
